Skip to main content
logo
GenFleet Therapeutics (Shanghai) Inc. (HKG:2595)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
33.00
+3.42 (11.56%)
Sep 30, 2026, 4:08 PM HKT

HKG:2595 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Revenue
84130.27104.773.73
Revenue Growth
-35.52%24.42%42.00%-
Gross Profit
34.5783.6684.6173.05
Operating Income
-389.5-279.98-305.6-285.83
Net Income
-1,316-1,795-677.64-508.32
Earnings Per Share
-2.81-6.07-2.62-2.31
EPS Growth
----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Cash & Investments
1,7902,075394.92332.2
Total Debt
138.8100.9269.3531.67
Net Cash (Debt)
1,6511,974325.57300.52
Net Cash Growth
-16.35%506.26%8.33%-
Net Cash Per Share
3.536.671.261.36

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Operating Cash Flow
-368.89-135.7-206.4-202.06
Capital Expenditures
-3.79-0.11-0.24-0.59
Free Cash Flow
-372.68-135.81-206.64-202.65
Free Cash Flow Growth
----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Gross Margin
41.16%64.22%80.81%99.07%
Operating Margin
-463.72%-214.93%-291.87%-387.66%
Pretax Margin
-1566.70%-1377.46%-647.20%-689.40%
Profit Margin
-1566.86%-1377.58%-647.20%-689.40%
FCF Margin
-443.69%-104.25%-197.35%-274.85%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
PS Ratio
126.0460.76--